Moreover, while VHL, PBRM1, SETD2, and BAP1 mutations are the most dominant in ccRCC, mutations of MET, SETD2, NF2, TP53, and PTEN are more common in papillary RCC and chromophobe RCC, respectively [17]. The gene discussed is MET; the disease is nonpapillary renal cell carcinoma.